Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The management of side-effects during therapy for hepatitis C Aspinall RJ; Pockros PJAliment Pharmacol Ther 2004[Nov]; 20 (9): 917-29The results of interferon and ribavirin combination therapy for chronic hepatitis C infection have substantially improved in recent years, such that the majority of patients in randomized-controlled trials now achieve a sustained virological response. However, adverse effects are commonplace, often disabling and may lead to interruption or cessation of therapy with subsequent loss of efficacy. Constitutional, neuropsychiatric and haematological reactions have proved particularly troublesome. In this review, we discuss these adverse effects in more detail and highlight recent advances in their management.|Antiviral Agents/*adverse effects[MESH]|Depressive Disorder/chemically induced[MESH]|Drug Carriers[MESH]|Drug Therapy, Combination[MESH]|Hematologic Diseases/chemically induced[MESH]|Hepatitis C, Chronic/*drug therapy[MESH]|Humans[MESH]|Interferon alpha-2[MESH]|Interferon-alpha/*adverse effects[MESH]|Polyethylene Glycols[MESH]|Recombinant Proteins[MESH]|Ribavirin/*adverse effects[MESH] |